e now have the first real-world data showing how well the monkeypox vaccine is working in the current U.S. outbreak.
By comparing the two, researchers were able to preliminarily quantify how effective the vaccine is, CDC director Dr. Rochelle Walensky said during a briefing.
The animal data provided a proxy for how well the shot would work in people, which now seems to be supported by real-world data.
The findings prompted the CDC to expand the group of people who are eligible for Jynneos to include those who might be at high risk of exposure to the virus; they can now use the vaccine as a way to protect themselves proactively.
Expanding eligibility will be “critical to making sure we keep getting vaccines into arms for both the first and second doses,” said Dr. Demetre Daskalakis, White House monkeypox response deputy coordinator, during the briefing.
Contact us at letters@time.com.
MobileNewspeparhttp
mobilenewspepar.com.